Summary
India's drug regulator has approved Takeda's Qdenga, making it the first dengue vaccine available in the country, with expected availability in the first half of 2027. The vaccine protects against all four dengue virus serotypes for individuals aged four to sixty and demonstrated significant efficacy in trials.